CVEvulnerability

CVE-2026-32979

7.0 HIGH Published 2026-03-29 Modified 2026-06-17 Official page ↗
Status
Analyzed
Published
2026-03-29
Last modified
2026-06-17
Assigner
[email protected]
CVSS 4.0 ([email protected])
7.0 HIGH — CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
7.3 HIGH — CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H
CVSS 3.1 ([email protected])
6.7 MEDIUM — CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
Weaknesses
CWE-367

Description

OpenClaw before 2026.3.11 contains an approval integrity vulnerability allowing attackers to execute rewritten local code by modifying scripts between approval and execution when exact file binding cannot occur. Remote attackers can change approved local scripts before execution to achieve unintended code execution as the OpenClaw runtime user.

Affected configurations

• openclaw openclaw (< 2026.3.11)

Related

Weakness · CWE (1)

  • CWE-367 Time-of-check Time-of-use (TOCTOU) Race Condition weakness

References